Polares Medical is an early and clinical-stage medical device company working on developing a technology that can address mitral valve regurgitation: a common cardiovascular disease. The company is based in Switzerland with Ra large office in Palo Alto, California. The company spun-out of Symetis (acquired by Boston Scientific) which developed a technology to treat aortic valve stenosis, to fully concentrate its efforts on the mitral valve of the heart.
Polares is currently developing a passive implant that would serve not as a repair nor a replacement of the Mitral Valve (MV) but as a partial replacement, which is a fast and cost-effective treatment than the current offering.